IF outsized executive pay has indeed become a source of outrage to American shareholders, then the contest this week between Pfizer Inc.'s investors and its board could prove the most compelling of the year.
The battle lines have been drawn between Pfizer's owners and managers, who will assemble on Thursday at the annual shareholder meeting in Lincoln, Neb., at the Cornhusker Marriott hotel.
